Products

What will AGI do for Acebutolol?

This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H28N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 67P356D8GH, chemically known as butanamide, n-(3-acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-,monohydrochloride,( -)- but generally known as acebutolol, which bears US NIH Compound Identifier 1978. Acebutolol most often comes in forms base, azide, hydrochloride, and methylboronate. European Medicines Agency schedules Acebutolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07371MIG. The term ACEBUTOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules acebutolol in its Anatomical Therapeutic Chemical (ATC) Classification. ACEBUTOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acebutolol under HS 29242995 and SITC 51479. As of Q4 2014, ACEBUTOLOL remains the US FDA Preferred Term for this commodity. Acebutolol bears US NLM identifiers UMLS ID C0000946 and NCI Concept Code C61525. SMILES: O(CC(O)CNC(C)C)C1C(CC(NC(=O)CCC)CC1)C(=O)C.